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Abstract 
 
 Dental caries is considered to be one of the most prevalent infectious disease in humans 
across all age groups because they affect 60-90% of the world’s population. With the 
introduction of refined sugar into the modern diet and an improved understanding of the 
pathogenesis of dental caries, the need for novel approaches to caries prevention has become 
is a key undertaking for addressing the caries burden in the 21st century. While previous studies 
have shown successful elimination of bacteria in the oral cavity, only a few modalities such as 
antimicrobial peptides, vaccines and more recently, nanoparticles, have been developed to 
specifically target Streptococcus Mutans. Here, we discuss the significance of the biofilm and 
the essential role of Strep. mutans in the development of dental caries. We focus on current and 
prospective therapeutic approaches against dental caries, including chemical modalities such as 
fluoride and chlorhexidine, vaccines, antimicrobial peptides, replacement therapy, quorum 
sensing targets, nanoparticles and natural products. Further research is needed to develop a 
safe and efficacious approach against caries, or specifically Streptococcus Mutans, in humans. 
 
 
 
 
 
 
 
 
 
 
I. Discussion of National and Worldwide Burden of Caries 
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 Dental caries is one of the most common childhood diseases. It is estimated that 
over 90% of the world’s population will experience dental caries at least once during 
their lifetime (Marchisio 2010). Dental caries is considered to be one of the most 
prevalent infectious disease in humans across all age groups because they affect 60-
90% of the world’s population (Petersen 2005).  
 
 Oral diseases and disorders affect health and well-being throughout life. 
According to the Oral Health in America: A Report of the Surgeon General in 2000, 
dental caries is the single most common chronic childhood disease - 5 times more 
common than asthma and 7 times more common than hay fever. Over 50% of children 
5-9 years old have at least one cavity or filling and that proportion increases to 78% 
among 17 year olds and 84.7% for adults 18 or older. Additionally, 49.7% of people 75 
years or older had root caries affecting at least one tooth (NCHS 1996, NHANES III). By 
age 17, more than 7.4% of US children have lost at least one permanent tooth because 
of caries; by age 50, Americans have lost an average of 12.1 teeth, including third 
molars. Dental caries is one of the primary causes of tooth loss among adults.  
 
 The social impact of oral diseases is substantial in children, amounting to more 
than 51 million school hours lost each year due to dental-related illness. Disparities in 
dental disease can be attributed to socioeconomic status. (Surgeon General’s Report 
2000). More than 1/3 (36.8%) of poor children aged 2-9 have one or more untreated 
decayed primary teeth, compared to 17.3% of non-poor children. Furthermore, the 
proportion of teeth affected by dental caries also varies by age and race/ethnicity. Poor 
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children from Mexican-American or non-Hispanic black backgrounds are at a higher risk 
group, with over 2/3 of this population having untreated decayed teeth. (NCHS 1996). 
 
 In the African American population, “baseline data for the Healthy People 2010 
objectives established that for children aged 2 to 4 years, 24.0 percent of non-Hispanic 
blacks have experienced dental caries in their primary teeth, compared to 15.0 percent 
for their non-Hispanic white counterparts.” (Surgeon General’s Report 2000). In the 
Asian and Pacific Islander American (APIA) population, “there is variation in oral health 
status among subgroups of children. In a recent survey in Hawaii, the prevalence of 
early childhood caries among APIA children was 16 percent, ranging from a low of 8 
percent among Japanese children to a high of 25 percent among Filipino children. The 
prevalence of untreated dental caries in 6- to 8-year-old APIA children was 39 percent, 
which ranged from a low of 16 percent among Japanese children to 40 percent among 
Native Hawaiians, 48 percent among Southeast Asians, and 62 percent among non-
Native Hawaiian Pacific Islanders (Greer 1999). (Surgeon General’s Report) In the 
Hispanic group, “preliminary data from NHANES III indicate that young Mexican 
American children aged 2 to 4 are more likely to have experienced dental caries in their 
primary teeth, have on average more decayed and filled tooth surfaces, and have more 
untreated disease than either non-Hispanic white or non-Hispanic black children (Kaste 
et al. 1996). Mexican American children aged 2 to 5 years—especially those from lower-
income households—were more likely than their African American and non-Hispanic 
white counterparts to have one or more decayed primary teeth (Vargas et al. 1998). A 
national survey found that employed Hispanic adults were twice as likely to have 
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untreated dental caries as non-Hispanic whites.(Watson and Brown 1995)” (Surgeon 
General’s Report 2000) 
 
 Healthy People 2020 has focused on 2 leading evidence-based interventions to 
prevent tooth decay: 1) Community water fluoridation and 2) School-based dental 
sealant programs. Community water fluoridation is an effective, safe and ideal public 
health measure which benefits individuals of all ages and socioeconomic status. Studies 
show that it can reduce tooth decay by 18-40%. However, over one third of the US 
population (100 million) do not currently benefit from this measure. (Surgeon General’s 
Report 2000). According to statistics from the Centers of Disease Control in 2013, over 
70% of US residents who rely on community water systems receive fluoridated water. 
CDC recognizes community water fluoridation as 1 of the 10 great public health 
achievements of the 20th century.  
School-based dental sealant programs usually target schools that serve children from 
low-income families. Dental sealants can prevent up to 60% of tooth decay in the 
treated teeth. (Ahovuo-Saloranta A et al 2013). Thirty six states reported dental sealant 
programs serving 258,000 children. This represents only about 8% of lower income 
children who could receive sealants. Currently used strategies for caries prevention 
such as oral health education, chemical and mechanical plaque control, use of fluorides, 
application of pit and fissure sealants are mostly broadly effective. (Surgeon General’s 
Report 2000) 
 According to the World Health Organization’s Report on ”Oral health: action plan 
for promotion and integrated disease prevention” in May 2007, future action calls for 
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further support for building at the national and community level, and implementing 
comprehensive and integrated oral-health programs, particularly in low and middle 
income countries and for poor and disadvantaged groups. In developing countries, 
dental caries remains in epidemic proportions. An oral health survey conducted in China 
revealed that 3 out of 4 5-year old children had evidence of significant dental decay. 
(Wong et al 2001). More effective public health measures are necessary to address this 
worldwide problem.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II. Understanding the Complexity of Biofilms 
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 While the pathogenesis of dental caries is complex, it often begins with 
cariogenic bacteria entering the dental biofilm at the early stages of life and 
subsequently emerging, under favorable environmental conditions to cause disease. 
(Smith 2002). In 1993, the term “Window of Infectivity” was coined by Caufield to 
describe the observation that children become permanently colonized with 
Streptococcus mutans between the middle of their second year and the end of the 3rd 
year of life under normal diet and environmental challenge. If infants fail to acquire 
Streptococcus mutans (MS) during this period they are unlikely to be colonized until 
around 6 years of age when the permanent molar teeth erupt. The higher the level of 
maternal strep mutans, the higher the percentage of children who become infected. 
(Kohler et al 1984). Though studies have shown that the primary source of infection is 
maternal, a few studies have also suggested that non-familial transfer can occur when 
the environmental conditions favor colonization (Mattos-Graner et al 2001). One of the 
most important virulence factors of cariogenic bacteria is their ability to adhere to oral 
surfaces and the colonization of subsequent bacteria to create biofilms.  
 
 Biofilms are complex microbial communities. A recent report using 
pyrosequencing analysis estimated the number of phylotypes in the oral cavity to be 
greater than 19,000 (Keijser et al 2008). This matrix consists mainly of hydrated 
polysaccharides, proteins, glycopeptides, extracellular DNA and lipids (Dong et al 
2002). A biofilm is usually polymicrobial, consisting of multiple organism species such 
as fungi, bacteria and viruses that exist at a phase or density interface, and encased in 
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a self-secreted extracellular matrix. The extracellular matrix which surround the bacteria 
reduces penetration of antimicrobial agents into the deeper layers of the biofilm. 
Cohabitation of multiple organisms not only creates competition for space but also 
promotes cooperative interactions such as horizontal gene transfer, metabolic 
cooperation and other synergies. This enhances the “survivability of microorganisms 
and resistance to antimicrobial agents” (Yang et al 2011; Wolcott et al 2013).  
 
 Since the biofilm responds as a community rather than as an assemblage of 
individual cells, cell-to-cell coordination, communication and signaling are imperative. 
Quorum sensing, the secretion and detection of a diffusible molecule by the community 
members can lead microbial species to suddenly change their behavior. One example is 
production of virulence factors (Remis et al 2010). There are 3 physiological properties 
of the biofilm that makes it an effective barrier that is difficult to overcome with 
therapeutics. (Hoiby et al 2010, Mah et al 2012) Firstly, there is a delayed or reduced 
penetration of any antimicrobials due repulsion and/or sequestration by the 
exopolysaccharide matrix. Secondly, the presence of metabolically inactive “persister” 
cells that are able to survive antimicrobial attacks, preventing complete elimination of 
the colony. Thirdly, due to close proximity of other cells, there is an increased possibility 
of exchange of mobile genetic elements encoding resistance. When cells exist in a 
biofilm, they can become 10-1000 times more resistant to the effects of antimicrobial 
agents. (Mah et al 2012) This presents a challenge in treatment targeting cariogenic 
bacteria which reside in the oral biofilm. 
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 The molecular pathogenesis of biofilm formation involves several phases. A 
saliva film containing albumin, glycoproteins, acidic proline-rich proteins, mucins, silica 
acids, and other compounds cover the tooth surface. This film called the acquired 
pellicle, provides receptors for the initial colonizers (Kreth et al 2009). Initial attachment 
to the tooth surface is achieved via interaction of bacterial proteins with lectins in the 
dental pellicle covering the tooth surface. (Smith et al 2002) Streptococcal adhesins, 
also known as antigen I/II or PAc in Strep mutans, bind to salivary components in 
experimental dental pellicles. The accumulation phase of acidogenic streptococci is 
then initiated by the activity of extracellular glucosyltransferases (GTF). Specifically 
GTF-B and GTF-C have been found to synthesize insoluble forms of glucan which is 
most closely associated with pathogenicity. In the presence of sucrose, GTFs 
synthesize several forms of high-molecular weight branched extracellular glucans. 
These glucans act as a scaffold for the aggregation of Strep mutans or other bacteria 
through the interaction with bacterial cell-associated glucan-binding domains of GTFs 
and Glucan Binding Proteins (GBPs). The succession of biofilm development involves 
congregation and coadherence of oral bacteria, and if undisturbed, develops into a 
stratified, complex biofilm. (Kreth et al 2009)  The last phase of pathogenesis is the 
production of lactic acid, a bacterial metabolic end product, which results in the erosion 
of hydroxyapatite-like mineral in dental enamel. It is critical to understand the intricacies 
of the dental biofilm in order to understand possible targets for anti-caries intervention.  
 
 The initial colonization process is dominated by oral streptococci, which make up 
over 80% of the early biofilm constituents (Rosan and Lamont, 2000) Current 
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approaches to biofilm control include either a therapeutic focus, with elimination of 
mature biofilms or a prophyolactic focus, preventing biofilm development by killing 
planktonic cells, disrupting their adhesion to a surface or inhibiting growth of attached 
cells in the early biofilm stage (Jorge et al 2012).  Strep mutans fuse with dental 
pellicles via 2 independent mechanisms: sucrose-dependent and sucrose independent. 
The sucrose dependent pathway involves the expression of antigen I/II (Mitchell 2003) 
and a virulence factor which binds the glycoprotein which coats teeth, salivary 
agglutinin. The sucrose independent pathway is more efficient and depends on glucans 
for attachment to the tooth surface. GTFs B, C and D produced by Strep. mutans 
convert sucrose to glucans.  
 
 
 
 
 
 
 
 
 
 
 
III. Historical Perspective of Cariogenic Bacteria 
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 W.D Miller first proposed the acid decalcification theory of dental caries in 1890. 
This theory involved 2 steps. Firstly, acid is produced from fermentable carbohydrate by 
bacteria in the mouth. Secondly, the acid dissolves tooth mineral resulting in a cavity. 
Miller considered that all bacteria in the mouth were potentially cariogenic, a concept 
now known as the “non-specific plaque hypothesis”. 
 
 In 1986, Loesche coined “specific/non-specific plaque hypothesis” for dental 
caries. The specific plaque hypothesis stated that Strep mutans is the primary cause of 
dental caries and treatment should be directed toward its elimination. The non-specific 
plaque hypothesis on the other hand stated that treatment of caries should be directed 
toward the correction or compensation of any oral microbiota imbalance. Bacteria are 
necessarily secondary and the promotion of oral bacteria that produce alkali is crucial. 
Additionally, the non-specific plaque hypothesis suggests that oral bacteria as a whole 
produce acid from fermentable carbohydrates. Therefore, the removal of as much 
plaque as possible is the appropriate treatment in dealing with caries.  
 
 While Clarke first isolated Strep mutans from carious lesions in 1924, it was a 
keystone study by Fitzgerald and Keyes in 1960, where direct evidence for involvement 
of specific microorganisms in dental caries was observed in albino hamsters. These 
hamsters only developed caries when caged together with other “caries-active 
hamsters”. This showed that specific microorganisms were involved in the induction of 
dental caries and that the disease was transmissible. Several studies led to the 
discovery of at least 8 serotypes of Strep mutans, which were grouped mainly into 4 
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species relevant to humans and small laboratory animals. Serotypes c, e and f 
remained Strep mutans. Serotype c Strep mutans strains are most frequently isolated 
from the human oral cavity (Loesche 1986) Serotype d, g and h became Strep sobrinus. 
Serotype a became Strep cricetus and serotype b became Strep rattus. Collectively, 
they are referred to as Mutans Streptococci (MS). Strep mutans and Strep sobrinus the 
are the most important in dental caries. In addition to Strep mutans, Lactobacilli have 
also been found to have an associative relationship with caries development. (Kleinberg 
2002) Though not essential in the caries process, lactobacilli have been found in sites 
favoring retention of fermentable carbohydrates or sites with dental appliances such as 
orthodontic bands. These sites have an elevated count of Lactobacilli and more 
acidogenic dental plaque.  
 
 In 2002, Kleinberg proposed the “mixed-bacterial ecological approach” as 
another model for caries development. This approach suggests that the proportion of 
acid-base producing bacteria is key in dental caries. Manipulating the proportion of 
arginolytic and non-arginolytic bacteria in the oral cavity changes the level of caries 
activity in an individual. Two landmark studies by Stephan in 1940 and 1944 
demonstrate that dental plaque produced rapid and substantial decreases in the pH in 
vivo. pH would substantially decrease following a sugar challenge and then slowly rise 
to baseline over an hour. The effects of saliva on the Stephan pH curve was studied. In 
the presence of saliva, there was a fall in pH to a minimum, then a subsequent slow rise 
toward baseline. In the absence of saliva, pH dropped significantly and then remained 
at a lower level for much of the experimental period. The rise part of the Stephan curve 
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was lost in the absence of saliva, possibly due to the absence of salivary bicarbonate 
(Wijeyeweera et al 1989). Through fractionation experiments, Kleinberg identified the 
pH-rise factor in saliva as arginine. Arginolytic bacteria produce base from arginine. 
Major acidogenic bacteria are non-arginolytic; they produce a pH fall but little or no pH 
rise. Other acidogenic bacteria also produced a pH fall but one that was less, because 
these bacteria produce base from arginine (arginolytics). Bacteria in plaque that are 
able to raise the pH by degrading arginine and producing base would be expected to 
produce less net acid and consequently be less or non-cariogenic. All Strep mutans are 
non-pH rising except Strep rattus, an arginolytic bacteria which has been associated 
with a caries free condition in both animals and humans (Kilian et al 1979). According to 
Kleinberg’s mixed- bacterial ecological approach, the ratio of arginolytic to non-
arginolytic bacteria is a key factor in the cariogenicity of the Stephan curve. A higher 
ratio is correlated with a less cariogenic Stephan pH curve whereas with the reverse a 
more highly cariogenic type of curve. A deficiency in base formation due to lack of saliva 
or a lower ratio of arginolytic to non-arginolytic bacteria can have similar cariogenic 
effects as an increased acid formation from a diet high in carbohydrates or a greater 
ratio of arginolytic to non-arginolytic bacteria.  
 
 
 
 
IV. Focus on Mutans Streptococci and its Virulence Factors 
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 MS possesses certain properties that enable them to predominate in dental 
plaque. The characteristics are: extracellular polysaccharide synthesis, acidogenicity 
(acid production), aciduricity (ability to survive in an acidic environment), intracellular 
polysaccharide (ICP) synthesis and endodextranase production. ICP is produced by 
some MS in the presence of carbohydrates. When carbohydrate is depleted, ICP can be 
metabolized leading to continued acid production. Studies of mutant Strep mutans 
which do not have the ability to produce ICP, while able to colonize teeth of rats, are 
relatively less cariogenic then non-mutant strains. Strep mutans is a key contributor to 
the polysaccharide rich extracellular matrix due to the production of glucans by three 
Gtfs: Gtf B synthesizes mainly insoluble glucans with alpha (1-3) glycosidic linkages, Gtf 
C synthesizes a mixture of insoluble and soluble glucans and Gtf D synthesizes 
predominantly soluble glucans with alpha (1-6) linkages. Gtf B and Gtf C are associated 
with the initial microbial adherence and structural stability of the extracellular matrix. 
GtfC has the greatest affinity for the hydroxyapatite surface, followed by Gtf B and Gtf 
D. (Koo 2010) A Gtf-targeted inhibitor can disrupt the formation of capsular-like glucans 
which make up the biofilm. Since this extra polysaccharide glucan matrix protects the 
microorganisms from antimicrobial agents, inhibiting glucan synthesis will allow 
substances such as fluoride or chlorhexidine to better penetrate the biofilm and 
enhance their biological efficacy. Another advantage of a Gtf-inhibitor is its ability to 
affect biofilm formation without directly killing bacterial cells. Poor biofilm formation is 
due to reduced adherence rather than cell death (Ren 2015). In this recent study, the 
author identified novel molecules that target Gtfs in order to inhibit Strep mutans biofilm 
formation. Structural based screening of approximately 150,000 commercially available 
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compounds was performed against the crystal structure of the substrate binding domain 
of the GtfC protein from Strep mutans. This resulted in the identification of a quinoxaline 
derivative 2-(4-methoxyphenyl)-N-(3{[2-(4-methoxyphenyl)ethyl]imino}-1,4-dihydro-2-
quinoxalinylidene) ethanamine as a potential Gtf inhibitor. This study suggests that a 
reduction in biofilm formation may be a better strategy to control caries formation as it 
does not disturb the remaining oral microbiota.  
 
 A study by Koo et al 2010 reported on the role of the Strep mutans gtf genes in 
development of micro colonies and the exopolysaccharide biofilm matrix. Mutants 
defective in gtfB and C genes showed a loss of ability to synthesize exopolysaccharide 
matrices, adversely affecting the development of micro colonies. GtfB and Gtfc also 
produce glucans which enhance the ability of Strep mutans to persist on apatitic 
surfaces and out compete other oral species. It has been suggested that micro colony 
development may be linked to bacterial virulence, therefore, this glucan-dependent 
mechanism has a significant effect on the survival of Strep mutans in complex biofilms. 
Development of the exopolysaccharide matrix and subsequent acidic niches has 
significant biological importance, creating shifts in the microbial population. As the 
environment becomes more acidic, Strep mutans have the ability to upregulate several 
stress survival pathways. GtfB, GtfC and glucan-binding proteins are further induced, 
leading to increased biofilm accumulation and colonization of other cariogenic species, 
such as Lactobacilli. This new environment provides a competitive advantage for all 
types of aciduric and acidogenic microflora. Consequently, these niches protected by a 
  
 
 17 
diffusion-limiting polymeric matrix results in a biofilm that is recalcitrant to antimicrobials 
and a challenge to disrupt. (Koo et al 2013)  
  
 Another study by Li et al 2010 showed that when Strep mutans were added to 
saliva biofilms that were allowed to grow for 16 hours, there was a 9 +/-0.4 (SD) fold 
reduction in Strep mutans incorporated into the biofilms as compared to Strep mutans 
inoculated with other bacteria and allowing the biofilm to form. This suggests that there 
is a protective colonization effect of a biofilm prior to addition of Strep mutans.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
V. Current and Prospective Therapeutic Approaches Against Dental Caries 
  
 
 18 
 A. CHEMICAL MODALITIES - FLUORIDE, CHLORHEXIDINE 
 
 Despite fluoride being the most effective anti-caries agent today (Clarkson, 
2000), dental caries remains a public health problem among underprivileged 
populations around the world. Numerous studies have investigated the effects of 
fluoride and chlorhexidine, both routinely used in clinical practice today, on caries 
development. Although fluoride’s effect on remineralization is well known, it also has 
important effects on bacteria in dental plaque (Marquis 1995). Fluoride acts directly to 
inhibit glycolytic enzyme enolase. Fluoride also enhances membrane permeability to 
protons and compromises the functioning F-ATPases in exporting protons. This induces 
cytoplasmic acidification and acid inhibition of glycolytic enzymes. (Marquis 1995). 
Fluoride reduces the acid tolerance of bacteria and is most effective at acidic pH values. 
Fluoride can prohibit glycolysis in Streptococcus mutans in acidic conditions. The 
anticaries effect of fluoride not only consists of remineralization but also inhibition of 
acidogenic bacteria in acidic conditions. 
  
  In an in vitro study by Savas 2015, the potency of 5 different substances, 1) 38% 
Silver Diamine Fluoride 2) Acidulated phosphate fluoride (APF) 3) Ammonium 
hexafluorosilicate (AHF) 4) Ammonium hexafluorsilicate + cetylpyridinium chloride (AHF 
+ CPC)  and 5) 0.2% chlorhexidine - were tested in reducing the number of viable 
microorganisms in biofilms. The number of viable bacteria was significantly reduced by 
all of the antibacterial agents. However, silver diamine fluoride (SDF) showed the 
highest antibacterial activity, with no viable microorganisms detected, while the 
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effectiveness of the other agents were lower. Another study also reported that after 
treatment of mature Strep mutans biofilms with SDF, the bacterial count decreased to 
zero (Chu et al 2012) SDF contains high concentration of silver (253,870ppm) and 
fluoride (44,800 ppm) ions. Silver ions are bactericidal metal cations that inhibit biofilm 
formation by inactivating and interfering with bacterial synthesis of cellular 
polysaccharides through inactivation of the glucosyltransferase enzymes responsible for 
the synthesis of soluble and insoluble glucans.  
 
 In a more recent study, a newly developed nano silver product was tested and 
evaluated for its antimicrobial and cytotoxicity activity against Strep. mutans. This 
product, known as nano silver fluoride (NSF), is a combination of silver nanoparticles 
and chitosan (Santos Jr VE 2014). From previous studies, it was noted that the 
antibacterial activity of silver nanoparticles increases as the particle size decreases. 
Chitosan is a biocompatible, biodegradable and non-toxic biopolymer obtained by the 
deacetylation of chitin. It has antibacterial activity against a broad spectrum of bacteria, 
including Strep mutans and Strep sanguinis (Targino 2014). The results from this study 
revealed that NSF may be effective against Strep mutans at much lower doses, does 
not stain teeth and may have lower toxicity than SDF. The biological effects and 
mechanism of action of fluoride has been well documented in a paper by Koo 2008. The 
paper discussed 2 major effects of fluoride on microbial cells: 1) direct inhibition of 
enzymes in cells, either directly of in the form of metal complexes (Marquis et al 2003) 
and 2) increasing proton permeability and acting as a transmembrane proton carrier. 
Fluoride inhibits the release of protons via F-ATPases by moving protons back into the 
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cell via HF. The cell is 10^7 times more permeable to HF then to F- (Marquis 2003). In 
the cytoplasm, HF dissociates to H+ and F- and the increased acidity inhibits glycolytic 
enzymes. Most chemotherapeutic strategies to enhance the biological activity of fluoride 
are based on the use of broad-spectrum antimicrobials, such as chlorhexidine, triclosan 
and metal ions/cations which also suppress resident flora (Koo 2008) 
 
 Several studies by Koo et al (2002, 2003, 2005) reported on strategies to 
enhance the biological effects of fluoride on dental biofilms. Apigenin and tt-farnesol, 
two naturally occurring compounds, have demonstrated anti-cariogenic activity against 
Strep. mutans in vitro and in vivo. Apigenin inhibits GTF-B and GTF-C and affects the 
expression of gtfB and gtfC genes, which are responsible for the synthesis of insoluble 
glucans. tt-farnesol disrupts the proton permeability of Strep. mutans membrane, 
inhibiting acid production and glucan synthesis by Strep mutans (Koo et al 2003, 2005). 
Topical application of apigenin and tt-farnesol reduced the incidence of dental caries 
with minimal effects on the viability of resident microflora in rats (Koo et al 2003). The 
combination of 1mM apigenin and 5mM tt-farnesol with 250-ppm fluoride was the most 
effective in reducing the biomass, polysaccharide content and acidogenicity of biofilms 
(Koo et al 2005).  
 
 Chlorhexidine (CHX) is still the most frequently used antimicrobial for reduction of 
plaque for caries control due to its broad antimicrobial spectrum.  However, 
chlorhexidine rinse has been approved for use to reduce gingivitis but not for caries 
prevention (Vollmer 2010). A study conducted in 2000 using a 10% chlorhexidine 
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varnish on adults with low salivary flow rates suggested a significant difference in 
varnish and placebo treatments on root caries (41% reduction) and total caries 
increment (25% reduction) (Banting 2000) In the study by Savas 2015, a single 
application of CHX was found to have significantly lower bactericidal activity compared 
to other agents such as SDF. Another study reported that a five-minute application of 
0.2% CHX did not significantly reduce the viability of microorganisms, however, a 60 
minute treatment resulted in a marked reduction in bacterial viability (Pratten et al 
1998). Another study reported that 0.2% CHX had an effect in inhibiting Strep mutans in 
6 hr biofilms, however its effect was limited to the outer layer of 48 hr dental plaque 
(Zaura-Arite et al 2001). Similarly, another study reported the application of 0.1% CHX 
for 1 or 5 min did not have a sufficient effect on 24 hr oral biofilm (Vitkov et al 2005).  
 
 
 
 
 
 
 
 
 
 
 
 B. VACCINES 
  
 
 22 
 
 Early studies of dental caries performed in rats employed whole cells of strep 
mutans as a possible vaccine (McGhee et al 1975). Later studies focused on vaccines 
manufactured from various cell-surface antigens of strep mutans and their recombinant 
fragments or synthetic peptides (Koga et al 1995, Kuramitsu, 1993). Animate 
(attenuated bacterial factors) and inanimate (liposomes, microparticles) delivery 
systems have been shown to provide efficient targeting of the vaccine. Both passive 
and active immunization approaches in animal models and human clinical trials have 
showed success in delaying the recolonization of Strep mutans.  
 
 Molecular targets that have been studied in dental vaccines consists of: 1) 
blocking receptors necessary for colonization (ex. Adhesins), 2) blocking receptors 
necessary for accumulation (ex. glucan-binding domains of GBPs and GTFs), 3) 
inactivating GTF enzymes responsible for glucan formation and 4) enhancing 
antimicrobial activity of salivary IgA or redirecting synergism with innate components of 
immunity such as mucin or lactoferrin. Strep mutans adhesins have been identified as 
antigen I/II, PAc or P1 and are responsible for initial attachment of bacteria to tooth 
surfaces.  There has been abundant in vivo and in vitro evidence to indicate that 
antibodies with specificity for Strep mutans PAc can interfere with bacterial adherence. 
PAc in different forms, as a full-length protein, recombinant or synthetic peptide (Smith 
2005), protein-carbohydrate conjugate (Wachsmann et al 1986) or DNA based active 
vaccines (Xu 2007), has been tested in experimental systems and proven as an 
effective immunogen. Glucosyltransferases produce soluble and insoluble glucans from 
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sucrose. Antibodies directed to native GTF or sequences associated with its catalytic or 
glucan-binding function disrupts the synthetic activity of the enzyme and consequently 
inhibit in vitro plaque formation (Smith et al 1978). Glucan binding proteins (GBPs) bind 
alpha-1,6-glucan and provide receptors for glucan-mediated aggregation in biofilm 
development. A study conducted in 1996 by Smith and Taubman in rats injected 
GBP59, glucosyltransferase (GTF) or phosphate buffered saline (sham) twice at 9-day 
intervals subcutaneously in the salivary gland vicinity with, with an adjuvant. Two weeks 
after the second injection, GBP59 and GTF injected rats contained significant levels of 
salivary IgA and serum IgG to the respective injected antigens. Rats were then infected 
orally with Strep mutans. Following 71 days of infection, GBP and GTF-injected groups 
had fewer Strep mutans on their molar surfaces compared with sham-injected infected 
groups. This suggests that immunization with Strep mutans GBP59 and GTF in rats 
induces an immune response upon future exposure to cariogenic streptococcus. 
 
 Active immunization and passive immunization against dental caries have been 
extensively documented in the literature. Many active immunization studies demonstrate 
the important anti-caries role of salivary IgA (Russell et al 1999). Salivary IgA is 
essentially absent at birth but the oral immune environment undergoes rapid 
development early in life. Mature salivary IgA is the principal salivary immunoglobulin 
secreted by individuals at 1 month of age, in addition to considerable concentrations of 
IgM. By 6-9 months, most children exhibit a more adult-like distribution of salivary IgA1 
and IgA2 subclasses (Smith et al 2002). By the second or third year of life, immune 
responses to streptococcal components such as antigen I/II, glucosyltransferase and 
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glucan-binding proteins are present and play a role in the ultimate colonization and 
accumulation of Strep mutans. Several studies have shown that mucosal exposure of 
humans to gluocosyltransferases of Strep mutans or Strep sobrinus can lead to 
formation of salivary IgA antibodies (Smith 2002). Five of 7 adults who were orally 
immunized using enteric coated capsules filled with Strep mutans GS-5 GTF antigen 
preparations contained in liposomes, had increased levels of parotid salivary IgA 
antibodies, primarily of the IgA2 subclass (Childers 1994).  
 
 Mucosal immunization with GTF could also influence the emergence of Strep 
mutans in young adults after dental prophylaxis. Young adults were given S. sobrinus 
GTF administered together with aluminum phosphate topically to the lower lip daily for 5 
days. Post dental prophylaxis, there was a delay in re-accumulation of indigenous oral 
mutans strep, compared with the placebo group given buffer-filled capsules. (Smith and 
Taubman 1987, 1990). Young adults between 18-42 years of age were screened for 
levels of antibody activity to GTF in parotid and labial gland salivas and levels of Strep 
mutans in their whole saliva. Prior to antigen administration, both active and placebo 
group had similar distributions of Strep mutans in their whole saliva. Although there was 
no statistical significant difference in anti-GTF IgA antibody activity in parotid or labial 
salivas between GTF-administered and placebo groups during the 6 weeks following 
topical application, the proportion of indigenous Strep mutans/total strep flora or total 
cultivable flora were always lower in whole salivas of the subjects immunized with GTF, 
compared with placebo. Delays in reaccumulation of microflora was significantly 
associated with elevations in parotid saliva IgA levels. (Smith and Taubman 1987, 1990) 
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 Passive immunization was tested in earlier studies using mouth rinses containing 
bovine milk (Filler et al 1991) or hen egg yolk IgY antibody (Hatta et al 1997) to Strep 
mutans. These studies led to modest short-term decreases in the numbers of 
indigenous strep in saliva or dental plaque. The effectiveness of a mouth rinse 
containing antibodies to Strep mutans in preventing the establishment of the bacteria in 
dental plaque was tested. Immune IgY inhibited Strep mutans adherence to saliva-
coated hydroxyapatite discs by 59.2%, while control IgY caused an inhibition of only 
8.2%. In the short-term (4-hour) test using a mouth rinse containing 10% sucrose, 
immune IgY decreased the ratio of the percentage of Strep mutans per total 
streptococci in saliva. with regards to the ratios of the percentage of Strep mutans per 
total streptococci in plaque of individual subjects, there was a tendency for a reduction 
of the ratios in the volunteers receiving the mouth rinse containing immune IgY. These 
results support the effectiveness of IgY with specificity to Strep mutans grown in the 
presence of sucrose as an efficient method to control the colonization of mutans 
streptococci in the oral cavity of humans. 
 
 A study by Ma et al in 1990 examined the long-term effects on indigenous 
microflora after topical application of mouse monoclonal IgG or transgenic plant 
secretory Secretory IgA/G antibody, with specificity for AgI/II. Subjects’ teeth were 
treated for 9 days with chlorhexidine, then antibody was topically applied for 3 weeks. 
The group treated with mouse monoclonal IgG did not experience recolonization with 
mutans for at least 2 years after treatment and the group treated with transgenic 
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antibody to the Ag I/II epitope did not experience recolonization for at least 4 months. 
Subjects who were treated with non-specific monoclonals had strep mutans 
recolonization within 82 days. No clinical side effects were reported in any of the 
subjects that received monoclonal antibody and there was no evidence of serum, 
salivary or gingival fluid antibody responses against the antibody. Other studies on 
experimental passive immunization demonstrated that protection could also be 
achieved with antibody to GTF (Hamada 1991) or GBP (Smith 2001). 
 
 Immunization via intranasal and oral routes have also been reported in previous 
studies. Mucosal application is generally preferred for induction of salivary IgA since 
mucosal IgA immune responses are most efficiently induced by administration of 
vaccines onto mucosal surfaces. The oral route is not ideal because the acidic stomach 
environment can diminish the effective antigen stimulus before uptake in the GALT (gut 
associated lymphoid tissue). Intranasal vaccination elicits both humoral and cell 
mediated antigen-specific immune responses and also requires a much smaller dose of 
antigen than oral vaccination for induction of antigen-specific mucosal and systemic 
immune responses. However, in order to develop an effective nasal associated 
lymphoid tissue (NALT) targeted vaccine delivery system, an adjuvant is necessary. A 
study that included salmonella-derived  protein at the time of pGJA-P/VAX 
administration resulted in an enhanced IgA and serum IgG antibody response (Shi et al 
2012). Flagellum is a ligand for Toll-Like Receptor 5 and is an attractive adjuvant 
because of its plasticity for generation of fusion proteins of recombinant vaccine 
antigens (Hayashi et al 2001). TLRs are membrane bound receptors that recognize 
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pathogen-associated molecular patterns (PAMPs) of invading microorganisms. Binding 
of TLRs to PAMPs triggers a series of events that activate the immune response.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 C. ANTIMICROBIAL PEPTIDES 
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 Between 1920 and 1950, several compounds with antimicrobial properties were 
isolated from secretions of living beings, and these compounds showed biological 
activity in small concentrations, with selectivity for both gram positive and negative 
bacteria. (Rocha da Silva 2012).  
 
 One of these compounds was known as Lactoferrin. Lactoferrin is an iron-binding 
protein found in the innate immune system of mammals biological fluids. It is known to 
exert broad-spectrum antimicrobial activity against bacteria, fungi, protozoa and viruses. 
Lactoferrin is known to penetrate the biofilm matrix and directly interact with cell 
membranes (Ammons et al 2009). Though the mechanism of lactoferrin in biofilm 
formation has yet to be fully elucidated, some research has attributed its antimicrobial 
activity to its iron chelating nature. Iron ions participate in a large number of biological 
processes in microorganisms and are essential in biofilm formation (Weinberg 2004).  
 
 Another group of compounds are known as cathelicidins. The cathelicidin 
proteins have highly conserved N-terminal cathelin domain regions and a C-terminal 
region that is less well conserved and carries antimicrobial properties. (Rocha da Silva 
2012) Only one cathelicidin has been identified in humans, derived proteolytically from 
the C-terminal end of the hCAP 18 protein. hCAP 18 is expressed by neutrophils and 
epithelial tissues in the oral cavity and respiratory tract. hCAP18 is expressed and 
cleaved by proteases to generate a 37 amino acid antimicrobial peptide known as LL-
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37. LL-37 has potent antimicrobial activity against Strep species and plays a role in 
chemotaxis and stimulation of monocytes, T cells, neutrophils and mast cells.  
 
 The histatins is another group of antimicrobial cationic proteins produced by the 
parotid, submandibular and sublingual glands. It exhibits apoptotic activities on 
microbes and fungi. Histatin-5 is a peptide composed of 24 amino acids and inhibits C. 
albicans. It binds to receptors on cell membrane and after internalization, inhibits 
mitochondrial respiration by forming reactive oxygen species which damages the 
mitochondrial and cytoplasmic membranes, leading to ATP efflux and cell death (Li et al 
2006).  
 
 Lastly, defensins are composed of more than 380 members, and each contains 
conserved motifs of 6 cysteine residues forming intramolecular disulfide bonds and beta 
sheets. They are expressed in response to micro-organism induced stress and play a 
role in the migration and activation of the innate immune system. (Diamond et al 2009) 
There are 2 types of defensins: alpha and beta, which are structurally similar but have 
distinct activities and production sites. Defensins cause cell rupture and inhibit 
lipopolysaccharide production in oral streptococci (Gomes et al 2010, Schmidt et al 
2011). The effect of beta-defensin 3 on 3 week old polymicrobial mature biofilm 
comprising of oral bacterial species A. naeslundii, L. salivarius, Strep mutans and 
E.Faecalis was tested using confocal microscopy and dead/live fluorescent staining 
(Lee et al 2013) Results from the study showed that 24 hour incubation of the biofilm 
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with hBD-3 (50ug/mL) resulted in a higher percentage of dead cells compared with both 
untreated samples and samples treated with common disinfectant solutions.  
 
 As discussed in earlier section on biofilms, targeting specific bacteria in this 
complex polymicrobial community is particularly challenging and may result in antibiotic 
resistance. Conventional treatment of infectious diseases with antibiotics results in 
killing of most members of the biofilm community, both pathogens and commensal 
bacteria (Frias-Lopez 2015). Broad killing of bacteria allows for equal competition 
between Strep mutans and nonpathogenic organisms to re-establish in the biofilm 
(Sullivan et al 2011). There is an increasing need to develop a specific antimicrobial 
therapy that can eliminate Strep mutans while leaving the remaining microorganisms in 
the oral biome intact.  
 
  Within the past decade, antimicrobial peptides (AMPs) have been receiving 
increased attention as potential therapeutic agents because they represent a novel 
class of antibiotics with a wide spectrum of activity and low rate of inducing bacterial 
resistance (Di Luca 2014). The number of articles on AMPs and biofilm had reached 
more than 60 in 2012 and more than 70 in 2013, whereas only a few (<5) articles were 
published in 2002-2003 (ISI web of science).  
 
 Antimicrobial peptides are active against a wide range of microorganisms and 
metabolically inactive cells. Their main mechanism of action includes permeabilization 
of the cellular membrane. This is the reason AMPs have very low bacterial resistant 
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rates as compared to common antibiotics. Emergence of resistance to bilayer-disruptive 
AMPs would entail changing membrane composition and organization, a “costly” 
process in evolutionary terms (Zasloff 2002). Since the risk to select resistant strains in 
biofilms is higher, AMPs are particularly suitable to treat biofilms because of the low rate 
of induced resistance and efficacy against a wide range of microorganisms.  
 
 AMPs are attracted to the surface of microorganisms by electrostatic interactions 
between anionic or cationic peptide and structures on the cell surface (Lee et al 2011). 
Several modeling studies have explored the mechanism of action of these antimicrobial 
peptides on cell death. After binding to the cell surface, AMPs initiate the attachment 
phase. In this phase, AMPs cross through the outer lipopolysaccharide membrane in 
gram-negative bacteria or the lipotechoic acid in gram positive bacteria. (Brogden 2005) 
There are three different models of membrane damage created by antimicrobial 
peptides. The first is the barrel-stave model where antimicrobial peptides in the 
membrane form a “barrel”, allowing flow of intracellular contents out into the 
extracellular environment. The second is the carpet model where AMPs accumulate 
parallel to the cell surface, oriented to penetrate the lipid bilayer and form pores for the 
entry of more peptides into the cell. Accumulation of peptides in the cell induces the 
formation of mycelia which are released from the membrane and leads to its 
disintegration. The third is the toroidal pore model where AMP helices are inserted into 
the cell membrane, leading to a connection of opposing lipid monolayers to each other. 
(Da Silva 2012) 
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 More recently, the discovery of Specifically Targeted Anti-Microbial Peptides 
(STAMP) has led to a more targeted approach to control oral microbial pathogenesis. A 
typical STAMP molecule consists of 2 functionally independent moieties conjoined in a 
linear peptide sequent - 1) a non-specific antimicrobial peptide serving as the killing 
moiety and 2) a species-specific binding peptide serving as the targeting moiety and 
provides specific binding to a selected pathogen and facilitates the targeted delivery of 
the antimicrobial peptide. A STAMP have been shown to be effective in eliminating 
Strep mutans from a mixed-species environment without affecting closely related non-
cariogenic oral streptococci (Eckert et al 2006).  
 
 In a study by Eckert, a pheromone produced by Strep mutans, known as the 
competence stimulating peptide (CSP) is used as the targeting domain for Strep 
mutans- specific delivery of the antimicrobial. The initial CSP-derived STAMP was 
constructed by synthesizing full-length Strep mutans CSP (21 amino acids) with the 
antimicrobial peptide G2 (16 amino acids derived from the antimicrobial peptide 
novispirin G10). This initial AMP did not reveal any antimicrobial activity possibly due to 
steric hindrance. Therefore, a shorter targeting domain (16 amino acids) was created. 
C16G2 consists of a Strep mutans-selective pheromone “targeting region” comprising a 
fragment of CSP (C16) conjoined to a novispirin-derived “killing region” consisting of a 
broad-spectrum antimicrobial peptide (G2). The C16G2 rinse was associated with 
reductions in plaque and salivary Strep mutans, lactic acid production and enamel 
demineralization. However, the impact on total plaque bacteria was minimal. Short 
exposure of C16G2 was capable of selectively inhibiting the growth of Strep mutans 
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within a multi species biofilm and in the presence of saliva for a minimum of 2 hours 
without disrupting the overall health of the biofilm (Hinkle 2013). C16G2 has a rapid 
mechanism of action working within less than 1 minute of exposure to bacteria. The 
half-life of C16G2 however was 18.8 minutes, suggesting it is unlikely to have 
meaningful effect in the oral cavity after long durations. The C16G2 rinse was also 
shown to significantly elevate resting pH of dental plaque in comparison to placebo 
rinse.  
  
 A study by Sullivan et al 2011 reported on the clinical efficacy of STAMP mouth 
rinse. The authors reaffirmed the need to develop a specific antimicrobial therapy to 
eliminate the primary cause of dental caries, Strep mutans from the oral biome without 
disrupting the remaining microflora. Broad killing of the bacteria allows for equal 
competition between Strep mutans and non-pathogenic organisms to re-establish 
themselves in the biofilm (Sullivan 2011) While previous studies by Eckert et al 2006 
has established efficacy and specificity against Strep mutans in biofilm communities and 
planktonic cultures, it was unclear whether C16G2 remained active in vitro as a mouth 
rinse. A 40s mouth rinse containing 0.04% C16G2 was administered once at the start of 
a 4-day test phase, and no fluoride tooth paste was used. Results showed that C16G2 
in 1xPBS (Phosphate Buffered Saline) reduced the viability of Strep mutans to below 
10% of mock-treated controls. This suggest that C16G2 was effective against Strep 
mutans at therapeutic concentrations of 25-100uM. Furthermore, in vitro hemolysis and 
tissue irritation assays were performed against human cells. C16G2 had no hemolytic 
activity against human RBCs at concentrations 100uM or less. Additional cytotoxicity 
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test using fully differentiated buccal (EpiOral) and gingival (EpiGingival) tissues from 
healthy donors were cultivated in-vitro and exposed to C16G2 (25 or 100uM). Results 
showed that no ET-50 (time to reduce tissue viability to 50%) could be obtained for 
STAMP-treated EpiOral and EpiGingival. To determine if the selective killing of Strep. 
mutans translated into a decrease in enamel demineralization, an intra-oral caries 
model was used. Enamel specimens were mounted in an upper palatal retainer and 
exposed to 10% sucrose challenges 4x daily. The results showed a 3.73% increase in 
enamel hardness relative to baseline in the C16G2 group, whereas a 23.0% loss of 
enamel hardness in the placebo rinse group. C16G2 was also shown to significantly 
elevate the resting pH of dental plaque relative to the placebo rinse (7.14 vs 6.66). This 
increase in pH has 2 benefits: Firstly, a higher resting pH promotes faster 
remineralization and decreases the severity of subsequent acid challenges. Secondly, 
higher resting pH encourages the growth of healthy bacteria and is unfavorable for 
cariogenic bacteria.  
 
 In another study by Wang et al 2015, a short synthetic amphiphilic peptide known 
as 1018 was effective in inhibiting biofilm development and killing of organisms in the 
biofilm. This anti-biofilm peptide binds to and stimulates the degradation of second 
messenger nucleotide (p)ppGpp, involved in biofilm formation and maintenance. 
10ug/ml of peptide 1018 (below MIC of >80ug/ml) had successfully inhibited plaque 
biofilm formation by suppressing more than 75% of biofilm growth, compared to the 
water control group. Peptide 1018 was not degraded by salivary mucins, unlike LL-37 
which had a decreased antimicrobial activity due to saliva (Bucki et al 2008). The study 
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also looked at the effect of peptide 1018 in combination with CHX to treat established 
plaque biofilms. While the combination of 1018 and CHX did not significantly reduce 
biofilm volume compared with each agent when used alone, the combined treatment led 
to significant increase in the amount of dead cells within the biofilms. 
 
 There have been several issues raised in previous studies on AMPs. Although 
the development of resistance to AMPs is slower than antibiotics, it is well established 
that bacteria adopt a variety of efficient strategies to resist even antimicrobial peptides. 
Some of the bacterial cationic antimicrobial peptides resistance mechanisms include 
electrostatic repulsion of CAMPs by modification of cell envelope molecules, proteolytic 
cleavage of CAMPs, production of CAMP-trapping proteins or extrusion of CAMPs by 
energy-dependent efflux pumps. Others have reported resistance to antimicrobial 
peptides is mainly based on the interaction with biofilm and capsule exopolymers. 
These polymers work by electrostatic repulsion and/or sequestration of these 
antibacterial substances (Kraus & Peschel 2006, Otto 2006). Other limitations to AMPs 
include potential toxicity, susceptibility to proteases and the high cost of peptide 
production. Designing the appropriate drug delivery system for AMPs is challenging 
because of enzymatic degradation and unfavorable physiochemical properties such as 
molecular aggregation and serum sequestration (Di Luca 2014). The high cationic 
activity of most AMPs in non-physiological conditions is usually significantly reduced in 
biological fluids such as plasma, serum or silver. It is also difficult to use parenterally 
because of high toxicity and quick renal excretion. (da Silva 2012)  
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 Current strategies under investigation include chemical modification, formulation 
vehicles and co-treatment with enzyme inhibitors or absorption enhancers. The use of 
peptido-mimetics is a strategy to avoid proteolytic degradation and the design of short 
peptides retaining antimicrobial activities is a solution to decreasing cost (Seo 2012). A 
study proposed that there was a protective colonization effect of biofilm from Strep 
mutans. They hypothesized that targeted elimination of Strep mutans leads to the 
generation of protective biofilms with the ability to prevent secondary surface 
colonization by Strep mutans (Li et al 2010). After 16 hours of inoculation of STAMPs 
with spectinomycin-resistant Strep mutans derivative JM11, there was no detectable 
Strep mutans cells in the sample while the untreated control contained ~10^7 Strep 
mutans cells in the biofilm. The efficacy of STAMP on shorter exposure duration times 
was also tested and results showed that biofilms treated for as little as five minutes 
contained approximately four (STAMPE 2_1G2) and five -(STAMP C16G2) orders of 
magnitude less Strep mutans cells. Furthermore, re-infection with Strep mutans was 
38+/- 13 (2_1G2) to 61 +/-13 fold (C16G2) significantly less in treated biofilms 
compared to untreated controls. The outcome of this study provided evidence for the 
protective effect of a “normal” oral biofilm similar to the concept of “window of infection” 
proposed by Caulfield et al 1993. In addition, the results suggests that whether naturally 
or through STAMP treatment, established Strep mutans-free biofilm reduces the 
competitive advantage of Strep mutans even in the presence of high sugar content, 
preventing the shift in biofilm composition toward cariogenesis (Li et al 2010).  
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 D. REPLACEMENT THERAPY 
 
 Several studies on replacement therapy were published in the early twenty-first 
century by the Hillman group. The basis of replacement therapy is the implantation of 
relatively innocuous “effector” bacteria that can competitively exclude or outgrow 
potentially disease-causing bacteria, without significantly disrupting the balance of the 
existing microbial system. Hillman identified 4 properties of an effective genetically 
modified effector strain for use in replacement therapy of dental caries. Firstly, it must 
have a significantly reduced pathogenic potential. Secondly, it must persistently and 
preemptively colonize the Strep mutans niche, preventing colonization by wild-type 
strains whenever the host comes into contact with them. Thirdly, it should be able to 
aggressively displace indigenous strains of Strep mutans, allowing even previously 
infected subjects to be treated with replacement therapy. Lastly, it must be generally 
safe and not predispose the host to other disease conditions (Hillman 2000).  
 
 They explored techniques for reducing cariogenicity in effector strains. Initially, 
mutants which had defects in glucan synthesis demonstrated reduced cariogenicity in 
animal models. However, they were unlikely to successfully outcompete glucan-
synthesizing strains for prime biofilm niches. Therefore, attention shifted toward 
introducing effector strains with mutations affecting acid production. These were called 
lactate dehydrogenase mutants (LDH). Lactate dehydrogenase mutants produced less 
lactic acid and had reduced cariogenicity in rodents, however, this mutation was lethal 
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in Strep mutans. A zygomonas mobilis gene encoding alcohol dehydrogenase was then 
inserted, also known as BCS3-L1 with virtual deletion of all the LDH gene. This created 
a strain that had traits of low acid production and strong mutacin production. BCS3-L1 
yielded final pH values that were 0.4-1.2 pH units higher than those of its parent. The 
reduced acidogenic potential is a major factor in its reduced cariogenic potential 
(Hillman 2000) 
 
 BCS3-L1 was created from a clinical Strep mutans isolate. Recombinant DNA 
technology was used to delete the gene encoding lactate dehydrogenase entirely and 
also designed to produce elevated amounts of novel peptide antibiotic known as 
mutacin 1140 (Hillman 2002), that gives it a strong selective advantage over most other 
strains of Strep mutans. Mutacin production was tested in a rat model and shown to be 
a phenotypic property that allows the bacteria to preemptively colonize and aggressively 
displace other bacteria. This was tested in a study by Hillman et al 1998. 3 years 
following a single, 3 minute infection regimen involving brushing and flossing, a 
concentrated cell suspension placed onto and between the teeth resulted in all human 
subjects remaining colonized by the mutant strain and producing a 3 fold elevated 
amount of mutacin 1140. Reacquisition of an acidogenic phenotype by spontaneous 
reversion is also extremely unlikely because of the deletion of the entire ldh gene in the 
construction of BCS3-L1.  
 
 One of the greatest advantages of replacement therapy is no need for patient 
compliance. However, there are several disadvantages with replacement therapy. 
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Firstly, even low-virulence colonizing strain can cause infections in immune-
compromised individuals. Secondly, the high intrinsic stability of the indigenous bacteria 
in the biofilm can present a major obstacle in introducing a new effector strain. Success 
is highly unlikely unless the effector strain is competitive (Hillman 2002). Alternatively, 
the effector strain could be introduced either before establishment of the microbial 
community, for instance in children immediately after the onset of tooth eruption and 
before their acquisition of a wild-type strain or upon creation of an appropriate niche 
following disruption of microflora by exposure to antimicrobials (Tagg 2003). Numerous 
early studies have reported on the difficulty in persistently introducing laboratory strains 
of Strep mutans into the mouth of humans, particularly after the indigenous microbiota 
has been established. (Krasse et al 1967l Jordan et al 1972; Ruangsri et al 1977; 
Svanberg et al 1981) 
 
 While creation of an innocuous effector strain has its challenges, studies have 
reported on other strains of Streptococci which can competitively inhibit caries-causing 
Strep mutans. A study by Becker et al in 2002 found that healthy subjects had 
significantly higher number of S. sanguinis, whereas subjects with caries possessed 
almost no detectable levels of S. sanguinis. High levels of S. sanguinis was correlated 
with delayed acquisition of Strep mutans. (Caulfield et al 2000).  
 
 It has been documented that Strep sanguinis, Strep gordonii and Strep mutans 
compete within the same niche. (Kreth et al, 2005). The success of colonization is 
determined by the sequence of establishment, nutritional availability and environmental 
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pressures. Strep mutans produce bacteriocins which can inhibit the growth of other 
streptococci. However, Strep gordinii and Strep sanguinis are able to inhibit the growth 
of Strep mutans by producing hydrogen peroxide (H2O2). Bacterocin production via the 
ComDE- QS system usually occurs with an increased amount of CSP when cell density 
is high. The production of H2O2 therefore, might provide an ecological advantage over 
bacteriocin production during the initial colonization, when cell density is not high 
enough to trigger bacteriocin production. H2O2 production is dependent on oxygen and 
usually occurs during initial colonization (Marquis 1995). Oxygen tension decreases 
after the biofilm reaches a certain thickness and cell density due to diffusion limitations. 
Subsequently under these conditions, Strep mutans has the competitive advantage 
producing bacteriocins to inhibit Strep gordonii and Strep sanguinis.  
 
 Wang and Kuramitsu (2005) reported that suppressants from Strep gordonii are 
able to inhibit the production of bacteriocins, but not affect the bacteriocins directly. 
They identified a protease called challisin, which is able to degrade CSP, and thus 
disrupt the bacteriocin/competence regulation cascade. A search of the Strep sanguinis 
genome also reveals a homolog of challisin. Another competitive inhibitor was identified 
as Strep oligofermentans. Strep oligofermentans is able to utilize lactic acid produced 
by cariogenic species such as Strep mutans to generate H2O2, consequently inhibiting 
Strep mutans. 
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 E. QUORUM SENSING TARGETS 
 
 Quorum sensing (QS) is a cell density dependent communication process that 
respond to the inter/intra-species signals and elicit responses to show behavioral 
changes in the bacteria to aggressive forms. Bacteria communicate with each other 
using hormone-like molecules known as pheromones, which increase in concentration 
as a function of bacterial cell density. (Leung et al 2015)  
 A major mechanism of signal transduction in bacteria is the so-called two-
component signal transduction system (TCTSs) (Li et al 2008), which enable bacteria to 
regulate their gene expression and coordinate activities in response to environmental 
stimuli. A typical TCTSs consists of a membrane-associated histidine kinase (HK) 
protein, which senses a specific stimulus, and a cytoplasmic response regulator (RR) 
protein, which enables the cells to respond to the stimulus via regulation of gene 
expression (Hoch, 2000).  
  
 In Strep Mutans, the QS system known as CSP-ComDE, is achieved by 
production and detection of signaling molecules in the form of a small peptide named 
CSP (competence-stimulating peptide) pheromone. The CSP pheromone accumulates 
not in proportion to typical cell density, but rather, to particular stresses in the oral 
cavity. This suggests that the pheromone probably functions as a stress-inducible 
alarmone, signaling bacteria in the biofilm to initiate an adaptive response that results in 
different phenotypic outcomes (Leung et al 2015). The CSP pheromone, once reaching 
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its threshold concentration, directly interacts with the membrane-bound histidine kinase 
receptor, ComD, to orchestrate a signaling response. The interaction of CSP 
pheromone with ComD triggers the dimerization and autophosphorylation of the 
receptor, and initiates the phosphorylation and subsequent activation of cytoplasmic 
response regulator ComE. Activated ComE directly activates the expression of several 
genes encoding bacteriocins and bacteriocin-like peptides and indirectly regulates SigX, 
involved in the control of the competence regulon.  
 
 Interference with the QS signaling is a promising avenue toward development of 
novel therapeutics. QS peptides could be useful for inducing targeting suicide. 
Alternatively, diminishing QS mechanisms could be considered to prevent persistence 
and genetic heterogeneity through the spreading of potential antibiotic resistance 
genes. (Leung 2015)  The ability to interfere with bacterial QS could manipulate the 
composition of pathogenic biofilms. Once the threshold concentration is reached 
(“quorum” or the number of bacteria required to activate the QS system), the QS 
molecule initiates a signaling cascade culminating in a population-wide differential 
regulation of target genes enabling bacteria to act as multicellular organisms. The CSP-
dependent QS system in Strep mutans has been found to regulate physiological 
activities including bacteriocin production, competence development, biofilm formation 
and stress response.  
 
 
  
 
 43 
 Bacterial programmed cell death is a kind of altruistic act that provides a way for 
species to survive stresses at the expense of some of its cells. Death by suicide of a 
subpopulation may leave more resources for the surviving population and thereby 
improve long-term survival of the species. Previous studies have shown that CSP-
induced PCD was involved in the release of extracellular DNA in the biofilm, 
“contributing to the architecture of the biofilm matrix and providing a mechanism for 
dissemination of fitness-enhancing genes under stress” (Leung 2015). In a study by 
Zhang et al 2009, late-stage biofilm formation by Strep mutans was significantly 
increased in the presence of exogenous CSP.  The addition of synthetic CSP correlated 
with cell death, release of genomic DNA, induced competence for DNA uptake and 
increased biofilm formation. Cell death benefits the attachment of surviving cells and 
induces subsequent biofilm differentiation and dispersal. (Bayles et al 2007, Petersen et 
al 2005) 
 
 Some bacteria enter a state of normalcy. These non-growing dormant cells 
known as persisters, are tolerant to all antibiotics currently in use without expressing a 
drug resistance mechanism (Leung 2015). Persisters are phenotypic variants of the 
wild-type strain that arise in a clonal population of genetically identical cells. Since 
persisters are in a growth-arrested physiological state, antibiotics that target essential 
cellular processes are ineffective in killing these cells. The formation of persisters has 
been described as “spontaneous” (Cohen 2013) and the existence of a small 
subpopulation of persisters in any growing bacterial population reflects a population-
level strategy of survival in a rapidly changing environment. QS-deficient mutants did 
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not demonstrate the ability to produce persister phenotypes which suggests that the 
CSP-ComDE QS system may be a deterministic mechanism for persister formation 
(Leung 2012). Recently, it was shown that an intact signal relay between ComDE, Com 
RS to the activation of SigX was required for the stress-induced persistence phenotype 
(Leung et al, 2015). These results showed the importance of the QS system in mounting 
an adaptive stress response within a subpopulation of S.mutans to form dormant 
persisters for survival of the species.  
 
 Among the therapeutic targets in QS system are CSP. STAMPs (selectively 
targeted antimicrobial peptides) were designed to have a targeted domain (8-amino acid 
region of the CSP) fused to an antimicrobial peptide domain and shows a robust 
species-specific activity that eliminates S.mutans without affecting the other non-
cariogenic streptococci. It was reported that C-terminal truncated CSP peptides could 
competitively affect the QS activity and structural motif in the C-terminal domain 
restoring the activation of the QS signal transduction pathway (Syvitski 2007). Another 
therapeutic target is the autoinducer-2 (AI-2). AI-2 is a furanosyl borate diester, known 
to mediate interspecies communication. AI-2 is encoded by the highly conserved luxS 
gene, and mutation in the luxS gene of Strep mutans leads to an altered biofilm 
structure and also decreases the production of bacteriocin and mutacin I (Yoshida et al 
2005, Merritt et al 2003). A study showed that synthetic furanone (Z)-5-
bromomethylene-2(5H)-furanone, a potential inhibitor of AI-2, was able to reduce biofilm 
formation in Strep anginosus, Strep intermedius and Strep mutans wild type strains, 
both when coated on a surface or when added to medium. (Lonn-Stensrud et al 2007) 
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The effect was more pronounced on furanone-coated surfaces, where the reduction 
was 76% and 63% in Strep intermedius and Strep mutans respectively. The reduced 
biofilm formation in all 3 streptococci studied demonstrated that the effect of furanone 
was not species specific. Furthermore, the furanone concentrations used had no effect 
on total growth of bacteria and therefore, reduces the risk of antimicrobial resistance 
development. Another therapeutic target is the ABC transporter (ComA), which play a 
vital role in the maturation and secretion of CSP (Kotake et al 2008). More specifically, 
the PEP domains of ComA would be an ideal target for the development of drugs to 
inhibit biofilm formation. Mutations at the active site of PEP has resulted in the complete 
loss of the catalytic activity of PEP domain. Based on the observation and substrate 
specificity of peptidase domain of ComA, Kaur et al 2015 hypothesized that the 
therapeutic inhibition of the PEP domain of ComA will halt the maturation and secretion 
of CSP from Strep mutans.  
 
 Another QS system known as HK/RR 11 is involved in Strep mutans survival at 
acidic pH. (Li et al 2008). Simultaneous inactivation of the ComCDE quorum-sensing 
system and HK/RR11 two-component regulatory system resulted in additive attenuation 
of the virulence and cariogenic potential of Strep mutans, since inactivation of either of 
these systems alone did not result in effects of the same degree or extent. This 
suggests that the ComCDE and HK/RR11 signal transduction systems function 
independently to regulate physiological activities, ecological fitness and virulence of 
Strep mutans (Li et al 2008). An interesting finding of this study was that inactivation of 
the ComCDE QS system alone did not affect oral colonization and succession of Strep 
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mutans in rats, however the caries score was significantly lower than that of the parental 
strain, indicating that colonization of Strep mutans in dental biofilms may not be 
sufficient to explain its virulence and cariogenic activity, although it is a pre-requisite for 
infection (Li et al 2008). The ComCDE system also controls production of several 
bacteriocin and bacteriocin immunity proteins. These compounds can kill other related 
species in favor of Strep mutans in the biofilm, and the release of DNA can be used by 
Strep mutans for genetic exchange (Kreth et al 2005) 
  
 Several recent studies have described the strategy and application of quorum-
sensing antagonists to prevent opportunistic infections caused by P. aeruginosa and S. 
aureus (Hentzer et al 2003). The major advantage in using anti-quorum-sensing 
compounds is that it specifically blocks or overrides bacterial signaling pathways that 
confer pathogenicity without significant effects on bacterial viability as a whole. When 
bacterial viability is not disturbed, there is much less selection pressure to create 
resistant microbes  (Li et al 2008).  
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 F. NANOPARTICLES 
 
 Nanoparticles are classified as particles with a size no greater than 100nm. Silver 
and copper have received the most attention in dentistry. An inverse relationship 
between the size of nanoparticles and antimicrobial activity has been demonstrated. a 
range of 1-10nm have been shown to have the greatest killing activity against bacteria 
compared with larger particles (Morones et al 2005) Bacteria are less likely to acquire 
resistance to metal nanoparticles compared to conventional broad-spectrum antibiotics 
because metals act on a broad range of microbial targets and many mutations would 
have to occur in order for micro-organisms to resist their antimicrobial activity (Allaker et 
al 2014) Metal oxides which produce a reactive oxygen species when exposed to UV 
light such as titanium dioxide (TiO2) and since oxide (ZnO) are increasingly used in 
antimicrobial applications (Allaker et al 2014)  
 
 A pertinent issue in restorative and preventative dentistry today involves the 
development of secondary caries. Traditional composites in vivo have been shown to 
accumulate more biofilms than other restorative materials. Plaque formation adjacent to 
restoration margins could result in secondary caries. More than half of all restorations 
fail within 10 years and 50-70% of all restorations placed are replacements of failed 
restorations (Cheng et al 2015). There has been a surge in focus on restorative 
materials which can minimize the risk of secondary caries. A study by Cheng et al 2015 
investigated the incorporation of nanoparticles of silver (NAg) into 
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composites/adhesives and quaternary ammonium methacrylates (QAMs) to combat 
biofilms. Nanoparticles of amorphous calcium phosphate (NACP) showed release of 
calcium/phosphate ions which remineralized tooth lesions and neutralized acids. The 
combination of NAg, QAM and NACP lead to the formation of a new class of 
composites and adhesives which is not only effective against bacteria but also promotes 
remineralization.  
 
 Silver has been extensively investigated for antimicrobial activity and is also 
relatively less toxic to human cells at very low concentrations. Silver has antibacterial, 
antifungal and antiviral properties. Though mechanism of action of Ag+ is not 
completely understood, studies have shown that the positive charge on Ag+ creates an 
electrostatic attraction between the negative charge of the bacterial cell membrane. 
Proteins in membrane or phosphorous containing elements such as DNA may be 
preferential binding sites for silver nanoparticles (Kim et al 2007) Nano Ag (Nag) has a 
high surface-area-to-mass ratio, hence a small amount of NAg was sufficient for the 
composite to be strongly antibacterial. Furthermore, a small amount of NAg did not 
compromise the color, esthetics or mechanical properties of the composite. (Cheng et al 
2015) Silver ions have the following 3 main antibacterial effects: destruction of cell wall 
structure; denaturation of cytoplasmic enzyme and inhibition of microbic DNA replication 
(Peng et al 2012). 
 
 In a study by Cheng et al. 2012, nano composites were developed containing 
amorphous calcium phosphate (ACP) or calcium fluoride (CaF2) nanoparticles and CHX 
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particles. Four nano composites were created with fillers: nano ACP, nano ACP + 10% 
CHX, nano CaF2, nano CaF2 + 10% CHX. Results showed that the release of CHX 
from the ACP nano composite was similar to that of the CaF2 nanocomposite. After 3 
days, the NanoCaF2 + CHX and NanoACP + CHX had pH levels that remained at 6.5 
or higher. For NaCaF2 alone, the pH dropped to 4.6, while NanoACP alone fell to a pH 
of 4.2. Furthermore, nano composites with CHX decreased CFU Strep. mutan counts by 
1000 fold compared to regular non-releasing composite. This study demonstrated that 
restorations that release CHX have the potential of eliminating bacteria in the vicinity. 
Consequently, this helps promote recolonization of the area with non-acidogenic 
bacteria and prevent recurrent caries. NanoCaF2 + CHX had a biofilm pH comparable 
to NanoACP + CHX, and the author proposed that this is likely due to the F ion release 
of CaF2. The F ion can help reduce acid production of bacteria, via inhibition of 
metabolic pathways. In addition to the anti-cariogenic activity of these nanoparticle 
materials, the flexural strength also remains comparable with commercial composites 
without fluoride.  
 
 Metal oxide nanoparticles have also been studied for its antimicrobial 
properties. The common oxides are those of copper, zinc, titanium and tungsten. Since 
metals target a broad range of microbial targets, development of resistance against 
metal oxide nanoparticles is highly unlikely (Allaker et al 2014). Zinc oxide has been 
shown to have a high degree of selective toxicity to bacteria and good biocompatibility. 
In a study by Eshed et al 2012, sonochemical coating of artificial teeth with ZnO and 
CuO nanoparticles significantly inhibited biofilm formation of Strep mutans. In another 
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study investigating the antibacterial properties of incoporating silver and zinc oxide 
nanoparticles in composite resins (Kasraei et al 2014), results showed that composite 
resins containing silver or zinc-oxide had a higher antibacterial activity against Strep 
mutans and Lactobacillus. Ramazanzadeh et al 2015 published findings on a study 
comparing the antibacterial effects of ZnO and CuO nanoparticles coated brackets on 
Strep mutans. The study found that CuO and ZnO-CuO nanoparticles coated brackets 
have better antimicrobial effect on Strep mutans than ZnO coated brackets. In fact, no 
colony growth was seen after 2 hours in both CuO and CuO-ZnO coated brackets. The 
growth of Strep mutans was significantly reduced by ZnO nanoparticles after 6-24 
hours. 
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VIII. NATURAL PRODUCTS 
 
 Natural products have been shown to inhibit bacterial growth, acid production 
and acidurance, exopolysaccharide synthesis and bacterial adherence. These products 
are usually associated with secondary metabolites produced by an organism, and there 
are 3 main groups: 1) phenolic compounds containing benzene rings, hydrogen and 
oxygen 2) alkaloids - nitrogen-containing compounds and 3) terpenoids - made from 
mevalonic acid and composed almost entirely of carbon and hydrogen.  
 Among the inhibitors of bacterial growth, Camellia sinensis has been shown to 
contain specific catechins from green tea which have antibacterial activity against S. 
mutants and S. sobrinus. The antibacterial inhibitory effect seems to be related to the 
“presence of three hydroxy moieties at 3’, 4’ and 5’ on the B ring of the catechin and 
epicatechin molecular structure”. (Sakanaka et al 1989). Essential oils affect the 
bacterial viability by compromising the integrity of the bacterial membrane. Terpenoids 
is the main chemical group. Thymol and eugenol inhibit a wide range of oral 
microorganisms including Strep mutans (Shapiro et al 1994). The antibacterial activity of 
tt-farnesol, oleic and linoleic acids may be related to their lipophilic characteristics and 
increase proton permeability.  
 Inhibitors of acid production and acidurance include 7-epiclusianone, tt-farnesol 
and some cranberry flavonoids. These have been reported to increase the proton 
permeability of Strep mutans cells, causing cytoplasmic acidification and inhibiting the 
acid-sensitive intracellular glycolytic enzymes (Koo et al 2010). Psidium chatelaine and 
epigallocatechin gullet have been shown to disrupt the expression and activity of 
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specific enzymes involved in the glycolytic pathway of Strep mutans, including lactate 
dehydrogenase. (Hirasawa et al 2006, Brighenti et al 2008) 
 Polyphenolic compounds have been extensively studied in their ability to reduce 
gluten synthesis and exopolysaccharide synthesis. Various polyphenols from the leaves 
of C.Sinensis (extracts of green or oolong tea), propolis, cacao bean husk, cranberry 
and often traditional plants (Serindeia warnecki, Azadirachta indica, R.gardneriana and 
M. chances) exhibit inhibitory effects against gluten synthesis (Jeon et al 2011). Most of 
the effective compounds in natural products have been found in polyphenolic 
compounds (Cheng et al 2015). 
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IX. CONCLUSION 
 
 Dental caries remains an infectious disease and a public health burden 
worldwide. Almost 95% of the world population is affected by caries at different ages. 
While usually not life-threatening, the development of cavities is inversely related to 
quality of life and overall health. (Sullivan 2011) With the introduction of refined sugar 
into the modern diet and an improved understanding of the pathogenesis of dental 
caries, the need for novel approaches to caries prevention has become is a key 
undertaking for addressing the caries burden in the 21st century.  
 Currently, the most effective measures against caries development is the use of 
fluoride-containing products, such as varnishes, toothpastes and silver diamine 
products. Individual behaviors with regard to oral hygiene and diet is also key in the 
balance between cariogenic and non-cariogenic plaque. (Sullivan et al 2011) The wide-
spectrum antibiotic use combined with emergence of drug resistant strains highlight the 
fundamental need for new “targeted” antibiotic therapies to combat specific mucosal 
pathogens with minimal impact on the remaining oral microflora (Eckert et al 2012). 
Furthermore, broad killing of bacteria results in equal competition between Strep 
mutans and nonpathogenic organisms in the re-establishment of the biofilm. 
 While fluoride is able to reduce the incidence and prevalence of dental caries and 
should remain an important component of oral health regimen, it has limited efficacy in 
killing cariogenic bacteria residing in dental plaque (Hamilton 1990). This could explain 
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the persistence of dental caries within populations, despite fluoride’s well documented  
clinical efficacy (Milgrom et al 2009, Anderson and Shi 2006).  
 Vaccines including both animate (attenuated bacterial factors) and inanimate 
(liposomes, microparticles) delivery systems have been shown to provide efficient 
targeting of Streptococcus mutans. Both passive and active immunization approaches 
in animal models and human clinical trials have shown success in delaying the 
recolonization of Strep mutans. (Russell et al 1999, Ma et al 1990) 
 Antimicrobial peptides have been receiving increased attention as potential 
therapeutic agents within the past decade because they represent a novel class of 
antibiotics with a wide spectrum of activity and low rate of inducing bacterial resistance. 
Specifically Targeted Antimicrobial Peptides (STAMPs) have been developed 
comprising of a species-specific targeting region, linker region and a wide-spectrum 
killing domain. STAMP treatment has received approval by the Food and Drug 
Administration to be studied as an Investigational New Drug and is currently in Phase II 
clinical trials for safety and efficacy. (Eckert et al 2006, 2012, Kaplan et al 2011)  
 Replacement therapy involves the implantation of relatively innocuous “effector” 
bacteria that can competitively exclude or outgrow potentially disease-causing bacteria, 
without significantly disrupting the balance of the existing microbial system. Many early 
studies however, have reported on the challenge in successfully introducing effector 
strains into the mouth of humans. (Hillman et al 2000, 2002, Tagg et al 2003) 
 Quorum sensing is the secretion and detection of a diffusible molecule by the 
community members can lead microbial species to suddenly change their behavior. 
Interference with the QS signaling is a promising avenue toward development of novel 
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therapeutics. QS peptides could be useful for inducing bacterial programmed cell death.   
The ability to interfere with bacterial QS could manipulate the composition of pathogenic 
biofilms. (Leung et al 2015)  
 Nanoparticles have become increasingly studied in its use in composite dental 
materials. This approach was developed with the goal of reducing the incidence of 
secondary caries. It has been reported that bacteria are less likely to acquire resistance 
to metal nanoparticles compared to conventional broad-spectrum antibiotics because 
metals act on a broad range of microbial targets and many mutations would have to 
occur in order for micro-organisms to resist their antimicrobial activity. (Allaker et al 
2014) 
 Lastly, natural products have been shown in in vitro experiments to inhibit 
bacterial growth, acid production and acidurance, exopolysaccharide synthesis and 
bacterial adherence. (Jeon JG 2011) The 3 main groups of natural products include 
phenolic compounds, alkaloids and terpenoids, of which phenolic compounds have 
been proven most effective. However, the specific mechanisms of anticaries effects are 
still unclear for most natural products. (Cheng et al 2015) 
 While these treatment modalities have been shown to target different virulence 
factors of Strep mutans, there is not one approach that has consistently shown a safe 
and efficacious approach against caries in humans. With the goal in mind to address the 
large caries burden worldwide, the next step would be to develop a new drug that could 
predictably and selectively target Strep mutans while being readily accessible to all 
populations regardless of socioeconomic status.  
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